Optimizing bioavailability in the treatment of Parkinson’s disease.

Seeberger, LC, and RA Hauser. 2007. “Optimizing Bioavailability in the Treatment of Parkinson’s Disease.”. Neuropharmacology.
Last updated on 11/05/2024